Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Stroke study seeks brain regions to boost arm healing

NCT ID NCT05313776

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to identify brain areas outside the main motor region that help arm recovery after a severe stroke. Researchers followed 28 patients over time, using MRI and movement tracking to see which brain areas became active as arm function improved. The goal was to find new spots for brain stimulation to enhance rehabilitation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

28 people

The number who actually took part.

Started

Feb 2022

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients admitted at the University hospital of Montpellier with an ischemic stroke that are meeting the inclusion criteria.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria patients post-stroke: * 18-85 yrs, * First ever ischemic stroke of the middle cerebral artery, * Initial severe motor deficit (fugl-Upper limb assessment score \<30/66), * Written consent. Exclusion criteria patients post-stroke: * The presence of secondary neurological or psychiatric deficits, * Strong hemineglect (bell-test); * Aphasie \>3/5 on the Boston scale, * Bilateral stroke, * Hemorraghic stroke, * MRI contra-indications, * Pregnancy/breastfeading, * Patient under curatele, * Medical urgency. Inclusion criteria healthy subjects: * Age matching (+/- 5 yrs), * Sexe matching, * Written consent. Exclusion criteria healthy subjets: * Neurological or psychological deficits; * MRI contra-indations; * Pregnancy/breastfeeding, * Personunder curatele.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ischemic stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Montpellier University Hospital

    Montpellier, 34090, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.